BioCardia, Inc. (BCDA)
NASDAQ: BCDA · IEX Real-Time Price · USD
2.06
+0.02 (0.98%)
At close:
Mar 24, 2023, 4:00 PM
2.08
+0.02 (0.97%)
After-hours:
Mar 24, 2023, 4:00 PM EDT
Income Statement (Annual)
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 - 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.02 | 0.15 | 0.71 | 0.63 | 0.48 | 0.58 | 0.9 | 0.43 | 0.27 | 0.06 | |
| Revenue Growth (YoY) | 600.00% | -79.58% | 13.60% | 30.48% | -16.84% | -36.28% | 111.71% | 59.33% | 332.26% | 416.67% | |
| Cost of Revenue | 0 | 0 | 0.36 | 0.52 | 0.69 | 0.75 | 1.06 | 0 | 0 | 0 | |
| Gross Profit | 1.02 | 0.14 | 0.35 | 0.11 | -0.21 | -0.17 | -0.16 | 0.43 | 0.27 | 0.06 | |
| Selling, General & Admin | 5.09 | 5.86 | 6 | 5.76 | 6.4 | 4.11 | 3.73 | 0.2 | 0.26 | 0.4 | |
| Research & Development | 8.56 | 9.81 | 8.56 | 8.45 | 5.8 | 3.33 | 1.52 | 0 | 0 | 0 | |
| Operating Expenses | 13.65 | 15.67 | 14.57 | 14.21 | 12.19 | 7.44 | 5.25 | 0.2 | 0.26 | 0.4 | |
| Operating Income | -12.63 | -15.53 | -14.21 | -14.1 | -12.41 | -7.61 | -5.41 | 0.23 | 0.01 | -0.34 | |
| Interest Expense / Income | 0 | 0 | 0.11 | 0 | 0 | 1.74 | 1.39 | 0 | 0 | 0 | |
| Other Expense / Income | -0.01 | -0.53 | 0.38 | -0.12 | -0.1 | 0.97 | -0.1 | -0 | -0.01 | -0.64 | |
| Pretax Income | -12.62 | -15 | -14.71 | -13.99 | -12.31 | -10.31 | -6.7 | 0.23 | 0.02 | 0.31 | |
| Net Income | -12.62 | -15 | -14.71 | -13.99 | -12.31 | -10.31 | -6.7 | 0.23 | 0.02 | 0.31 | |
| Net Income Growth | - | - | - | - | - | - | - | 1131.58% | -93.77% | -96.84% | |
| Shares Outstanding (Basic) | 17 | 10 | 6 | 4 | 4 | 1 | 0 | 2 | 2 | 2 | |
| Shares Outstanding (Diluted) | 17 | 10 | 6 | 4 | 4 | 1 | 0 | 2 | 2 | 2 | |
| Shares Change | 67.19% | 79.27% | 32.37% | 0.57% | 356.02% | 436.33% | -91.87% | - | - | - | |
| EPS (Basic) | -0.75 | -1.48 | -2.61 | -3.28 | -2.90 | -11.07 | -38.61 | - | - | - | |
| EPS (Diluted) | -0.75 | -1.48 | -2.61 | -3.28 | -2.90 | -11.07 | -38.61 | - | - | - | |
| Free Cash Flow Per Share | -0.62 | -1.22 | -1.70 | -2.61 | -2.08 | -5.94 | -41.23 | 0.10 | 0.01 | -0.14 | |
| Gross Margin | 100.00% | 97.24% | 49.58% | 17.28% | -44.05% | -29.51% | -17.37% | 100.00% | 100.00% | 100.00% | |
| Operating Margin | -1244.33% | -10709.66% | -2001.83% | -2256.32% | -2589.77% | -1320.83% | -598.34% | 54.10% | 3.36% | -546.77% | |
| Profit Margin | -1243.65% | -10347.59% | -2071.69% | -2237.92% | -2569.52% | -1789.93% | -740.82% | 54.80% | 7.09% | 491.94% | |
| Free Cash Flow Margin | -1032.71% | -8544.14% | -1350.85% | -1781.60% | -1838.62% | -958.68% | -790.71% | 50.12% | 10.07% | -500.00% | |
| EBITDA | -12.56 | -14.93 | -14.05 | -13.9 | -12.23 | -8.54 | -5.26 | 0.23 | 0.02 | 0.31 | |
| EBITDA Margin | -1237.73% | -10298.62% | -1978.31% | -2223.84% | -2553.24% | -1481.77% | -582.30% | 54.80% | 7.09% | 491.94% | |
| Depreciation & Amortization | 0.06 | 0.07 | 0.55 | 0.09 | 0.08 | 0.04 | 0.05 | 0 | 0 | 0 | |
| EBIT | -12.62 | -15 | -14.6 | -13.99 | -12.31 | -8.57 | -5.31 | 0.23 | 0.02 | 0.31 | |
| EBIT Margin | -1243.65% | -10345.52% | -2055.92% | -2237.92% | -2569.52% | -1488.54% | -587.50% | 54.80% | 7.09% | 491.94% |
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).